A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

Journal of Internal Medicine

Volumn 254, Issue 2, 2003, Pages 184-192

  Tønnesen, Philip ^a   Tonstad, S ^b   Hjalmarson, A ^c   Lebargy, F ^d   Van Spiegel, P I ^e   Hider, A ^f   Sweet, R ^f   Townsend, J ^f  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d HÔPITAL MAISON BLANCHE   (France)

^e SLOTERVAART HOSPITAL   (Netherlands)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bupropion sustained release; Randomized controlled trials; Smoking cessation; Weight gain; Withdrawal symptoms

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BIRTH DEFECT; CHOLECYSTITIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FALLING; FEMALE; HEADACHE; HUMAN; INFLUENZA; INSOMNIA; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOMES RESEARCH; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SMOKING CESSATION; STILLBIRTH; SUSTAINED RELEASE PREPARATION; SYNCOPE; TASTE DISORDER; URTICARIA; VERTIGO; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 0041842752     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01185.x     Document Type: Article

References (26)

1. Hurt RD. Sachs DPL. Glover ED et al. A comparison of sustained-release bupropion SR and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-202.
2. Jorenby DE, Leischow SJ, Nides MA et al. A controlled trial of sustained-release bupropion SR, a nicotine patch. or both for smoking cessation. N Engl J Med 1999; 340: 685-91.
3. Tashkin DP. Kanner RE. Bailey WC et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571-75.
4. Hays JT. Hurt RD. Rigotti NA et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomised controlled trial. Ann Intern Med 2001: 135: 423-33.
5. Holm KJ, Spencer CM. Bupropion. A review of its use in the management of smoking cessation. Drugs 2000; 59: 1007-24.
6. Heatherton TF. Kozlowski LT. Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991: 86: 1119-27.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA. Washington, 1994.
8. Jarvis MJ. Russell MA. Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. BMJ 1980; 281: 484-5.
9. Welsch SK, Smith SS, Wetter DW. Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol 1999: 7; 354-61.
10. Gart J. Point and interval estimation of the common odds ratio in the combination of 2 x 2 tables with fixed marginals. Biometrika 1970; 57; 471-5.
11. Cox DR. A simple example of a comparison involving quantal data. Biometrika 1966; 53; 215-20.
12. Russell MA, Stapleton JA, Feyerabend C et al. Targeting heavy smokers in general practice; randomised controlled trial of transdermal nicotine patches. BMJ 1993; 306: 1308-12.
13. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people to stop smoking: results of a randomised trial in general practice, BMJ 1993; 306: 1304-8.
14. Hays JT, Hurt RD, Rigotti NA et al. Sustained-release bupropion SR for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med 2001; 18: 423-33.
15. Gonzales DH, Nides MA, Ferry LH et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion SR: a randomized placebo-controlled study. Clin Pharmacol Ther 2001: 69: 438-44.
16. Tønnesen P, Nørregaard J. Mikkelsen K, Jørgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993: 269: 1268-71.
17. Tønnesen P, Nørregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-5.
18. Hjalmarson A, Nilsson F, Sjöström L, Wiklund O. The nicotine inhaler in smoking cessation. Arch Intern Med 1997; 157: 1721-8.
19. Hjalmarson A, Franzon M, Westin A, Wiklund O. Effect of nicotine nasal spray on smoking cessation. A randomized. placebo-controlled, double-blind study. Arch Intern Med 1994: 154: 2567-72.
20. Hjalmarson AI. Effect of nicotine chewing gum in smoking cessation. A randomized. placebo-controlled, double-blind study. JAMA 1984; 252: 2835-8.
21. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-months results from two multicenter controlled clinical trials. JAMA 1991: 266: 3133-8.
22. Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Int Med 1993: 153: 1881-90.
23. Shiffman S. Johnston JA, Khayrallah M et al. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 2000; 148: 33-40.
24. Kwan AL, Meiners AP, van Groorheest AC, Lekkerkerker JFF. Risk of convulsions due to use of bupropion SR as an aid for smoking cessation. Ned Tijdschr Geneeskd 2001; 145: 277-8.
25. Humma LM, Swims MP. Bupropion mimics a transient ischemic attack. Ann Pharmacother 1999; 33: 305-7.
26. Bhattacharjee C, Smith M, Todd F, Gillespie M. Bupropion overdose: a potential problem with the new "miracle" anti-smoking drug. Int J Clin Pract 2001: 55: 221-2.